Your browser doesn't support javascript.
loading
Enhanced antiviral benefit of combination therapy with anti-HBV and anti-PD1 gRNA/cas9 produces a synergistic antiviral effect in HBV infection.
Zhen, Shuai; Qiang, Rong; Lu, Jiaojiao; Tuo, Xiaoqian; Yang, Xiling; Li, Xu.
Afiliação
  • Zhen S; Medical Heredity Research Center, Northwest Women's and Children's Hospital, Shaanxi, PR China. Electronic address: usa_2002@163.com.
  • Qiang R; Medical Heredity Research Center, Northwest Women's and Children's Hospital, Shaanxi, PR China.
  • Lu J; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China.
  • Tuo X; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China.
  • Yang X; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China.
  • Li X; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China.
Mol Immunol ; 130: 7-13, 2021 02.
Article em En | MEDLINE | ID: mdl-33340931
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Hepatite B / RNA Guia de Cinetoplastídeos / Receptor de Morte Celular Programada 1 / Sistemas CRISPR-Cas / Edição de Genes / Hepatite B Limite: Animals / Female / Humans Idioma: En Revista: Mol Immunol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Hepatite B / RNA Guia de Cinetoplastídeos / Receptor de Morte Celular Programada 1 / Sistemas CRISPR-Cas / Edição de Genes / Hepatite B Limite: Animals / Female / Humans Idioma: En Revista: Mol Immunol Ano de publicação: 2021 Tipo de documento: Article